After the development of cytokeratin 20 (CK20) as an antibody in the early 1990s, the diagnosis of MCC became simpler and more reliable, and the reported incidence of MCC increased significantly, partly explaining why this rate has tripled in the last 20 years [83]. The gene discussed is KRT20; the disease is Merkel cell skin cancer.